Kostrzak, A
Caval, V
Escande, M
Pliquet, E
Thalmensi, J
Bestetti, T
Julithe, M
Fiette, L
Huet, T
Wain-Hobson, S
Langlade-Demoyen, P
Article History
Received: 30 March 2016
Revised: 26 October 2016
Accepted: 11 November 2016
First Online: 18 November 2016
Competing interests
: AK, ME, EP, JT, TB, MJ and TH are employees of Invectys. PLD and SWH are co-founders of Invectys, a biotech devoted to therapeutic cancer vaccination. The remaining authors declare no conflict of interest.